# EDGAR Filing Document

**Accession Number:** 0001069899
**File Stem:** 0001104659-25-091656
**Filing Date:** 2025-9
**Character Count:** 7073
**Document Hash:** 96dab69a10bd246eaf0e0c129d6c347e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-091656.hdr.sgml**: 20250919

**ACCESSION NUMBER**: 0001104659-25-091656

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250919

**DATE AS OF CHANGE**: 20250919

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PHIBRO ANIMAL HEALTH CORP
- **CENTRAL INDEX KEY:** 0001069899
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 131840497
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36410
- **FILM NUMBER:** 251327000

**BUSINESS ADDRESS:**
- **STREET 1:** GLENPOINTE CENTRE EAST, 3RD FLOOR
- **STREET 2:** 300 FRANK W. BURR BLVD., SUITE 21
- **CITY:** TEANECK
- **STATE:** NJ
- **ZIP:** 07666
- **BUSINESS PHONE:** 201-329-7300

**MAIL ADDRESS:**
- **STREET 1:** GLENPOINTE CENTRE EAST, 3RD FLOOR
- **STREET 2:** 300 FRANK W. BURR BLVD., SUITE 21
- **CITY:** TEANECK
- **STATE:** NJ
- **ZIP:** 07666

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PHILIPP BROTHERS CHEMICALS INC
- **DATE OF NAME CHANGE:** 19980908

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

------

**SCHEDULE 14A**

**Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934**

**(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)**

------

---

| | | |
|:---|:---|:---|
| Filed by the Registrant | Filed by the Registrant | ☒ |
| Filed by a Party other than the Registrant | Filed by a Party other than the Registrant | ☐ |
| Check the appropriate box:  | Check the appropriate box:  | Check the appropriate box:  |
| ☐ | Preliminary Proxy Statement | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 | Soliciting Material under §240.14a-12 |

---

------

**Phibro Animal Health Corporation**

**(Name of Registrant as Specified In Its Charter)**

------

**(Name of Person(s) Filing Proxy Statement, if other than the Registrant)**

------

---

| | |
|:---|:---|
| Payment of Filing Fee (Check the appropriate box):  | Payment of Filing Fee (Check the appropriate box):  |
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |

---

------

![Graphic](pahc-20250919xdefa14a006.jpg)

Phibro Animal Health Corporation

Glenpointe Centre East, 3<sup>rd</sup> Floor

300 Frank W. Burr Blvd., Ste 21

Teaneck, NJ 07666

**Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting To be held on Tuesday, November 4, 2025**

Dear Stockholder:

You are receiving this notice to inform you that the proxy materials for our 2025 Annual Meeting of Stockholders are available on the internet. In accordance with rules adopted by the U.S. Securities and Exchange Commission, we are using the internet as our primary means of furnishing proxy materials to our stockholders. This communication presents only an overview of the more complete proxy materials that are available to you on the internet. We encourage you to access and review all of the important information contained in the proxy materials before voting.

The proxy statement and annual report to stockholders are available at: http://www.astproxyportal.com/ast/18918/. If you want to receive a paper or e-mail copy of these documents, you must request one by sending an e-mail to investor.relations@pahc.com or by calling +1 (201) 329-7331. You will have the opportunity to make a request to receive paper copies for all future meetings or only for the 2025 Annual Meeting of Stockholders. There is no charge to you for requesting a copy. Please make your request for a copy on or before October 20, 2025 to facilitate timely delivery. We encourage you to access and review all of the important information contained in the proxy materials before voting.

The 2025 Annual Meeting of Stockholders (the "Annual Meeting") of Phibro Animal Health Corporation (the "Company") will be held at 9:00 A.M. Eastern Time on Tuesday, November 4, 2025, at the Company's offices located at Glenpointe Centre East, 3rd Floor, 300 Frank W. Burr Blvd., Suite 21, Teaneck NJ 07666. Only holders who owned shares of the Company's Class A common stock and Class B common stock as of the close of business on September 12, 2025 (the "Record Date"), may vote at the Annual Meeting or any adjournment or postponement of the Annual Meeting that may take place.

Proposals to be voted on at the Annual Meeting are listed below along with the Board of Directors recommendations:

● the election of the following three Class III Directors to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified:

● Jack C. Bendheim

● Alejandro Bernal; and

● E. Thomas Corcoran

The Board of Directors recommends that you vote **FOR** this proposal.

● a proposal to approve, on an advisory basis, the compensation of our named executive officers.

------

The Board of Directors recommends that you vote **FOR** this proposal.

● a proposal to approve, on an advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officers.

The Board of Directors recommends that you vote, on an advisory basis, for holding future stockholder advisory votes on the compensation of our named executive officers every **3 YEARS**.

● a proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending June 30, 2026.

The Board of Directors recommends that you vote **FOR** this proposal.

You may access the following proxy materials at http://www.astproxyportal.com/ast/18918/:

● Notice of the 2025 Annual Meeting of Stockholders;

● The Company's 2025 Proxy Statement;

● The Company's Annual Report on Form 10-K for the Fiscal Year Ended June 30, 2025; and

● The Proxy Card.

If you are a stockholder of record, there are two ways to vote:

● by completing and mailing your proxy card; or

● by written ballot at the Annual Meeting.

Stockholders of record as of the Record Date are encouraged and cordially invited to attend the 2025 Annual Meeting of Stockholders. Stockholders may request directions to the Company's offices in order to attend the Annual Meeting by calling +1 (201) 329-7331.

---

| |
|:---|
| By order of the Board of Directors, |
| /s/ Judith A. Weinstein |
| Judith A. Weinstein |
| Senior Vice President, General Counsel and Corporate Secretary |
| September 19, 2025 |

---

------